Tuberculosis Diagnostics Market Size, Share, Competitive Landscape and Trend Analysis Report

 For organizations targeting expansion, this report delivers actionable intelligence on how the tuberculosis diagnostics industry is evolving.

 

 How Big Is The Tuberculosis Diagnostics Market In 2025?
 The tuberculosis diagnostics market size has grown strongly in recent years. It will grow from $2.21 billion in 2024 to $2.34 billion in 2025 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to the rise in the incidence of tuberculosis, increased healthcare expenditure, growth in the number of healthcare facilities, and the rise in the adoption of nucleic acid testing.
 
 The tuberculosis diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.15 billion in 2029 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to strong government support, the increasing FDA approvals for tuberculosis diagnostics, the increasing research and development (R&D) activities, and the emergence of drug-resistant TB. Major trends in the forecast period include a focus on next-generation sequencing (NGS) platforms for TB diagnostics, product innovations, t-cell tests for TB infection, artificial intelligence (AI)-based tuberculosis diagnostics, use of portable devices, and collaborations between governments and manufacturers.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=8165&type=smp
 
 What Are The Major Factors Driving The Tuberculosis Diagnostics Global Market Growth?
 The rise in the incidence of tuberculosis is driving the demand for the tuberculosis diagnostics market going forward. Tuberculosis is an infectious disease that affects the lungs and can be severe. Tuberculosis is spread through coughing and sneezing, releasing tiny germs into the air. Tuberculosis diagnostics aid in patient detection, with earlier diagnosis and detection of diseases. For instance, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the rise in the incidence of tuberculosis drives the tuberculosis diagnostics market. Therefore, the rise in the incidence of tuberculosis is driving the growth of the tuberculosis diagnostics market.
 
 Tuberculosis Diagnostics Market Report Segmentation Analysis
 The tuberculosis diagnostics market covered in this report is segmented — 
 
 1) By Test Type: Radiographic Tests, Nucleic Acid Testing, Cytokine Detection Tests, Drug Resistance Tests, Skin Test / Mantoux Test (TST), Blood/Serology Test, Smear Microscopy Tests, Cell Culture-Based Tests, Other Test Types
 2) By Disease Stage: Latent Tuberculosis, Active Tuberculosis
 3) By End-User: Hospitals And Diagnostic Laboratories, Physician’s Office Laboratories, Reference Laboratories, Academics And Research Facilities
 
 Subsegments:
 1) By Radiographic Tests: Chest X-rays, CT Scans 
 2) By Nucleic Acid Testing: Polymerase Chain Reaction (PCR), Nucleic Acid Amplification Tests (NAATs) 
 3) By Cytokine Detection Tests: Interferon Gamma Release Assays (IGRAs) 
 4) By Drug Resistance Tests: GeneXpert MTB/RIF, Line Probe Assays 
 5) By Skin Test or Mantoux Test (TST): Tuberculin Skin Test (TST) 
 6) By Blood Or Serology Test: Serological Tests for Antibodies 
 7) By Smear Microscopy Tests: Acid-Fast Bacilli (AFB) Smear Test 
 8) By Cell Culture-Based Tests: Solid Media Cultures, Liquid Media Cultures 
 9) By Other Test Types: Molecular Tests, Advanced Imaging Techniques 
 
 What Are The Prominent Trends In The Tuberculosis Diagnostics Market?
 Technological innovations are the key trend gaining popularity in the tuberculosis diagnostics market. Major companies operating in the market are introducing new technologies, such as advanced point-of-care (POC) diagnostic methods that work on AI technology to sustain their position in the market. For instance, in August 2022, Fujifilm, a Japan-based company engaged in the manufacturing of medical imaging devices, partnered with Qure.ai, a US-based company engaged in the development of AI-enabled medical imaging solutions, and launched an advanced point-of-care (POC) diagnostic method. A battery-powered X-ray machine is used in this method for tuberculosis diagnosis. With the help of artificial intelligence, algorithms help in effective testing programs, offering ultra-portability, high accuracy, and efficient point-of-care diagnostic solutions.
 
 What Are The Top Players Operating In The Tuberculosis Diagnostics Market?
 Major companies operating in the tuberculosis diagnostics market include Beckton, Dickinson and Company, F. Hoffmann-La Roche Ltd, Qiagen N.V, BioMerieux SA, Danaher Corporation, PerkinElmer, Thermo Fisher Scientific Inc., Creative Diagnostics, Lionex GmbH, Biocartis, Bio-Techne India Private Limited, Bio-Rad laboratories India Pvt.Ltd, Zhejiang Di’an Diagnostics Technology Co., Ltd, ADICON Clinical Laboratories, Guangzhou Kingmed Diagnostics Center Co. Ltd., Kindstar Global, OriGene Technologies, Siemens AG, LumiraDx Limited, TestLine Clinical Diagnostics s.r.o., Hologic, Bayer AG, Meridian Bioscience, Abbott laboratories Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc, Agilent technologies Inc, Akonni Biosystems Inc, Epistem Limited, Gen-Probe, Sysmex South Africa (Pty) Ltd., Bio Certica, BixBio 
 
 View the full tuberculosis diagnostics market report here:
 https://www.thebusinessresearchcompany.com/report/tuberculosis-diagnostics-global-market-report
 
 Which Region Holds The Largest Market Share In The Tuberculosis Diagnostics Market?
 Asia-Pacific was the largest region in the tuberculosis diagnostics market in 2024. The regions covered in the tuberculosis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company